In what can be considered as a major development in the on-going battle against the COVID-19 pandemic, a patent has been granted for a homeopathic medicine which is effective against COVID-19 infection. Particularly, a patent has been granted to Dr. Rajesh Shah for a nosode composition which can be used for the prevention, alleviation and treatment of COVID-19 infection.
Three hundred and twelve (312) high risk individuals, i.e., persons exposed to individuals who have tested positive for COVID-19, were administered the nosode composition and of these 312 individuals, only 1.6% (5 individuals) of the individuals subsequently tested positive for COVID-19. As further determined by way of clinical trials, the nosode composition exhibits immunomodulatory effects when used on healthy human volunteers and also causes activation of innate immunity. Development of antibodies was also observed in few of the volunteers proving that the composition invokes an immune response in individuals.
It is also of great significance that the Ministry of Ayush has recognized that the nosode composition falls under the category of New Homeopathic Drug and directed that Dr. Rajesh Shah can apply to the Drugs Controller General of India (DCGI) for the necessary approval; a process which is currently underway.
Hence, there is hope that widespread use of this nosode composition will result in better management of COVID-19 infections and soften the physical, mental and financial blow dealt to humanity in case of resurgence of infections.